Clinical Trial: Atezolizumab for Idiopathic Pulmonary Fibrosis
Study Status: Completed
Recruit Status: RECRUITING
Condition: Idiopathic Pulmonary Fibrosis
Study Type: INTERVENTIONAL
Official Title: A Phase I Study to Evaluate the Safety and Preliminary Efficacy of Atezolizumab in Idiopathic Pulmonary Fibrosis
Brief Summary:
The purpose of this study is to determine the safety and preliminary efficacy of atezolizumab, an immune checkpoint inhibitor approved for the treatment of various cancers, in patients with idiopathic pulmonary fibrosis (IPF).
Read more